ABSTRACT
RATIONALE: Ayahuasca is a psychotropic plant tea from South America used for religious purposes by indigenous people of the Amazon. Increasing evidence indicates that ayahuasca may have therapeutic potential in the treatment of mental health disorders and can enhance mindfulness-related capacities. Most research so far has focused on acute and sub-acute effects of ayahuasca on mental health-related parameters and less on long-term effects. OBJECTIVES: The present study aimed to assess sub-acute and long-term effects of ayahuasca on well-being and cognitive thinking style. The second objective was to assess whether sub-acute and long-term effects of ayahuasca depend on the degree of ego dissolution that was experienced after consumption of ayahuasca. RESULTS: Ayahuasca ceremony attendants (N = 57) in the Netherlands and Colombia were assessed before, the day after, and 4 weeks following the ritual. Relative to baseline, ratings of depression and stress significantly decreased after the ayahuasca ceremony and these changes persisted for 4 weeks. Likewise, convergent thinking improved post-ayahuasca ceremony up until the 4 weeks follow-up. Satisfaction with life and several aspects of mindfulness increased the day after the ceremony, but these changes failed to reach significance 4 weeks after. Changes in affect, satisfaction with life, and mindfulness were significantly correlated to the level of ego dissolution experienced during the ayahuasca ceremony and were unrelated to previous experience with ayahuasca. CONCLUSION: It is concluded that ayahuasca produces sub-acute and long-term improvements in affect and cognitive thinking style in non-pathological users. These data highlight the therapeutic potential of ayahuasca in the treatment of mental health disorders, such as depression.
Subject(s)
Banisteriopsis , Cognition/drug effects , Hallucinogens/pharmacology , Personality/drug effects , Plant Extracts/pharmacology , Psychotropic Drugs/pharmacology , Thinking/drug effects , Adult , Affect/drug effects , Depression/diagnosis , Ego , Female , Humans , Netherlands , Personal Satisfaction , South America , Stress, Psychological/diagnosisABSTRACT
Serotonin is well known for its role in affection, but less known for its role in cognition. The serotonin transporter (SERT) has an essential role in serotonergic neurotransmission as it determines the magnitude and duration of the serotonin signal in the synaptic cleft. There is evidence to suggest that homozygous SERT knockout rats (SERT(-/-)), as well as humans with the short SERT allele, show stronger cognitive effects than wild-type control rats (SERT(+/+)) and humans with the long SERT allele after acute tryptophan depletion. In rats, SERT genotype is known to affect brain serotonin levels, with SERT(-/-) rats having lower intracellular basal serotonin levels than wild-type rats in several brain areas. In the present study, it was investigated whether SERT genotype affects memory performance in an object recognition task with different inter-trial intervals. SERT(-/-), heterozygous SERT knockout (SERT(+/-)) and SERT(+/+) rats were tested in an object recognition test applying an inter-trial interval of 2, 4 and 8 h. SERT(-/-) and SERT(+/-) rats showed impaired object memory with an 8 h inter-trial interval, whereas SERT(+/+) rats showed intact object memory with this inter-trial interval. Although brain serotonin levels cannot fully explain the SERT genotype effect on object memory in rats, these results do indicate that serotonin is an important player in object memory in rats, and that lower intracellular serotonin levels lead to enhanced memory loss. Given its resemblance with the human SERT-linked polymorphic region and propensity to develop depression-like symptoms, our findings may contribute to further understanding of mechanisms underlying cognitive deficits in depression.
Subject(s)
Brain Chemistry/genetics , Genetic Predisposition to Disease/genetics , Memory Disorders/genetics , Serotonin Plasma Membrane Transport Proteins/genetics , Serotonin/metabolism , Animals , Brain/metabolism , Brain/physiopathology , Cognition Disorders/genetics , Cognition Disorders/metabolism , Cognition Disorders/physiopathology , Depressive Disorder/genetics , Depressive Disorder/metabolism , Depressive Disorder/physiopathology , Disease Models, Animal , Gene Knockout Techniques , Genotype , Memory Disorders/metabolism , Memory Disorders/physiopathology , Rats , Recognition, Psychology/physiology , Serotonin Plasma Membrane Transport Proteins/metabolismABSTRACT
In 1984 the Dental Attitudes Questionnaire, an instrument for assessing oral health care attitudes, was proposed. The DAQ has six content scales (Cynicism, Health Concern, Motivation, Oral Function, Social Aesthetic, Susceptibility) and two validity scales (Halo, Infrequency). The original items had an 'agree-disagree' format. We compared this dichotomous format with a six-point response format. Results obtained with the two-point scale did not meet acceptable psychometric criteria. The six-point scale resulted in acceptable item and subtest parameters and variance, internal reliability and test/retest reliability. For eight items, rewording was suggested. Future research is indicated.
